AU2021318236A1 - Aqueous composition - Google Patents

Aqueous composition Download PDF

Info

Publication number
AU2021318236A1
AU2021318236A1 AU2021318236A AU2021318236A AU2021318236A1 AU 2021318236 A1 AU2021318236 A1 AU 2021318236A1 AU 2021318236 A AU2021318236 A AU 2021318236A AU 2021318236 A AU2021318236 A AU 2021318236A AU 2021318236 A1 AU2021318236 A1 AU 2021318236A1
Authority
AU
Australia
Prior art keywords
mass
aqueous composition
acid
salt
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021318236A
Other languages
English (en)
Inventor
Saeko Hayashi
Akiko Kita
Ozora Kubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of AU2021318236A1 publication Critical patent/AU2021318236A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2021318236A 2020-07-30 2021-07-30 Aqueous composition Pending AU2021318236A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-129728 2020-07-30
JP2020129728 2020-07-30
PCT/JP2021/028439 WO2022025279A1 (ja) 2020-07-30 2021-07-30 水性組成物

Publications (1)

Publication Number Publication Date
AU2021318236A1 true AU2021318236A1 (en) 2023-03-09

Family

ID=80036428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021318236A Pending AU2021318236A1 (en) 2020-07-30 2021-07-30 Aqueous composition

Country Status (9)

Country Link
US (1) US20230285562A1 (https=)
EP (1) EP4176882A4 (https=)
JP (1) JPWO2022025279A1 (https=)
KR (1) KR20230047400A (https=)
CN (1) CN116568285A (https=)
AU (1) AU2021318236A1 (https=)
CA (1) CA3190310A1 (https=)
TW (1) TWI908843B (https=)
WO (1) WO2022025279A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024194105A1 (en) * 2023-03-17 2024-09-26 Leo Pharma A/S A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema
EP4506005A1 (en) * 2023-08-09 2025-02-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap
WO2025032221A1 (en) * 2023-08-09 2025-02-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2018229A1 (en) * 1970-04-16 1971-10-28 Ferrous sulphate stabilized with citric acid
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
JP6427497B2 (ja) * 2013-10-21 2018-11-21 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤
CA2991020A1 (en) 2015-07-07 2017-01-12 Japan Tobacco Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
TWI790218B (zh) 2016-12-21 2023-01-21 日商日本煙草產業股份有限公司 7Ｈ－吡咯并[2,3－ｄ]嘧啶衍生物的製造方法及其共結晶
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
CN119367282A (zh) * 2019-12-27 2025-01-28 乐敦制药株式会社 水性组合物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Also Published As

Publication number Publication date
TWI908843B (zh) 2025-12-21
WO2022025279A1 (ja) 2022-02-03
CA3190310A1 (en) 2022-02-03
CN116568285A (zh) 2023-08-08
EP4176882A1 (en) 2023-05-10
KR20230047400A (ko) 2023-04-07
TW202220658A (zh) 2022-06-01
JPWO2022025279A1 (https=) 2022-02-03
US20230285562A1 (en) 2023-09-14
EP4176882A4 (en) 2024-01-10

Similar Documents

Publication Publication Date Title
AU2021318236A1 (en) Aqueous composition
KR102580933B1 (ko) 아트로핀-함유 수성 조성물
CA3190313A1 (en) Aqueous composition
KR0159768B1 (ko) 안정한 주사용 수성 조성물 및 그러한 조성물의 안정화 방법
JPWO2021039748A1 (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
KR20010012521A (ko) 방부 조성물
JP7597714B2 (ja) 涙液分泌促進用眼科組成物
US20250288575A1 (en) Eye drop composition for prevention or treatment of ophthalmic diseases and preparation method therefor
JP7722931B2 (ja) 水性組成物
JP4168071B2 (ja) 点眼用組成物
JP5753958B2 (ja) 澄明な水性液剤
BR112020024481A2 (pt) formulações/composições compreendendo ibrutinib
KR101805939B1 (ko) 치환된 감마 락탐을 함유하는 안과 제제 및 이의 사용 방법
HK40091721A (zh) 水性组合物
HK40091389A (zh) 水性组合物
JP5489581B2 (ja) プラノプロフェン含有水性組成物
Jadhav et al. Development and Characterization of In-Situ Gel Forming Ophthalmic Formulation of Carteolol.
IE62756B1 (en) Pharmaceutical aqueous solution for ophthalmic use comprising a water soluble pharmaceutically acceptable acid addition salt of ibopamine
WO2024204749A1 (ja) 眼科組成物
EP4534082A1 (en) Ophthalmic composition
KR20250030490A (ko) 안과 조성물
AU672879B2 (en) Aqueous pharmaceutical compositions of arginine amide
HK40066213A (zh) 泪液分泌促进用眼科组合物
HK40003059B (zh) 含有阿托品的水性组合物
HK40004290B (en) Atropine-containing aqueous composition